Evidence map›Paper›PMID 38565976›Full record

ArticleNature chemistry2024

A directed enolization strategy enables by-product-free construction of contiguous stereocentres en route to complex amino acids.

Fenglin Hong, Timothy P Aldhous, Paul D Kemmitt, John F Bower

Abstract read
In one paragraph

Article in Nature chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Direct, Asymmetric, and Stereodivergent Reactions ofThe Journal of organic chemistry · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fenglin HongDepartment of Chemistry, University of Liverpool, Liverpool, UK.
Timothy P AldhousDepartment of Chemistry, University of Liverpool, Liverpool, UK.ORCID 0000-0003-2031-7454
Paul D KemmittMedicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK.ORCID 0000-0002-5374-6557
John F BowerDepartment of Chemistry, University of Liverpool, Liverpool, UK. john.bower@liverpool.ac.uk.ORCID 0000-0002-7551-8221

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 863799RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/M507994/1
6 · The paper itself

Abstract

Homochiral α-amino acids are widely used in pharmaceutical design as key subunits in chiral catalyst synthesis or as building blocks in synthetic biology. Many synthetic methods have been developed to access rare or unnatural variants by controlling the installation of the α-stereocentre. By contrast, and despite their importance, α-amino acids possessing β-stereocentres are much harder to synthesize. Here we demonstrate an iridium-catalysed protocol that allows the direct upconversion of simple alkenes and glycine derivatives to give β-substituted α-amino acids with exceptional levels of regio- and stereocontrol. Our method exploits the native directing ability of a glycine-derived N-H unit to facilitate Ir-catalysed enolization of the adjacent carbonyl. The resulting stereodefined enolate cross-couples with a styrene or α-olefin to install two contiguous stereocentres. The process offers very high levels of regio- and stereocontrol and occurs with complete atom economy. In broader terms, our reaction design offers a unique directing-group-controlled strategy for the direct stereocontrolled α-alkylation of carbonyl compounds, and provides a powerful approach for the synthesis of challenging contiguous stereocentres.

Indexed as

AlkenesAmino AcidsIridiumCatalysisGlycineMolecular StructureStereoisomerismAlkenesAmino AcidsGlycineIridium

Identifiers

PMID38565976
PMCPMC11230901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.